Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-14 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.32 | 4e-10 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-08 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-07 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-06 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |